Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Julie Parmentier | Researchclopedia

Back to researchers

Julie Parmentier

AbbVie (United States)ORCID

33

Works

1,370

Citations

11

h-index

11

i10-index

Research Topics

T-cell and B-cell Immunology Cytokine Signaling Pathways and Interactions Urticaria and Related Conditions

Affiliations

AstraZeneca (United Kingdom)2014–2014

University College Ghent2012–2012

AbbVie (United States)2018–2025

Clinique Saint Pierre1997–1998

Centre Hospitalier Universitaire Dijon Bourgogne2008–2008

Top Works

Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody

Ross Stewart,Michelle Morrow,et al.

2015402 citations

Dermatology and Skin Diseases

Chronic Lymphocytic Leukemia Research

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)

Julie Parmentier,J W Voss,et al.

2018361 citations

Upadacitinib: Mechanism of action, clinical, and translational science

Mohamed‐Eslam F. Mohamed,Sumit Bhatnagar,et al.

2023127 citations

Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2

Joseph M. Gozgit,Geraldine Bebernitz,et al.

2008101 citations

Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases

Peter C. Taylor,Ernest Choy,et al.

202381 citations

The role of Janus kinase signaling in the pathology of atopic dermatitis

Emma Guttman‐Yassky,Alan D. Irvine,et al.

202379 citations

Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma

Scott A. Ezell,Michele Mayo,et al.

201454 citations

Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy

Geoffrey S. Williams,Bina Mistry,et al.

201654 citations

An anti–TNF–glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases

Michael Mcpherson,Adrian D. Hobson,et al.

202424 citations